The number of ROR1 molecules present in the cell membrane per tumour cell, as well as the minimum amount of ROR1 positive tumour cells per cancer lesion required to secure therapeutic success are relevant aspects that cannot be addressed by this kind of prevalence analysis. Here, ROR1 is linked to neoplasm.